scispace - formally typeset
R

Robert W. Schrier

Researcher at University of Colorado Denver

Publications -  595
Citations -  41275

Robert W. Schrier is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Vasopressin & Renal function. The author has an hindex of 99, co-authored 586 publications receiving 38996 citations. Previous affiliations of Robert W. Schrier include Parke-Davis & University of Texas Health Science Center at San Antonio.

Papers
More filters
Journal ArticleDOI

National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

TL;DR: To deal with the exceedingly difficult health care issues posed by frail elderly persons, health professionals need to collect, organize, and use a vast array of clinically relevant information.
Journal ArticleDOI

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension

TL;DR: In this population of patients with diabetes and hypertension, a significantly higher incidence of fatal and nonfatal myocardial infarction is found among those assigned to therapy with the calcium-channel blocker nisoldipine than among those assign to receive enalapril.
Journal ArticleDOI

Acute renal failure and sepsis.

TL;DR: The substantial progress in understanding the mechanisms of sepsis-associated acute renal failure is discussed, which is associated with an ominous 70 percent mortality.
Journal ArticleDOI

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

TL;DR: Intensive BP control in normotensive type 2 diabetic patients: (1) slowed the progression to incipient and overt diabetic nephropathy; (2) decreased the progression of diabetic retinopathy; and (3) diminished the incidence of stroke.
Journal ArticleDOI

Acute renal failure: definitions, diagnosis, pathogenesis, and therapy

TL;DR: The epidemiology and pathophysiology of ARF are discussed, including the vascular, tubular, and inflammatory perturbations and implications for potential future therapies to decrease the high mortality.